Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
PubMed · Dimeric Erythrina alkaloids as well as their key units from Erythrina variegata. (2022)
PubMed · <i>Erythrina variegata</i> L. bark: an untapped bioactive source harbouring therapeutic properties for the treatment of Alzheimer's disease. (2021)
Révisé par : HerbAlly Editorial Team, Medical herbalists and healthcare professionals
Dernière mise à jour : April 2026
Calculer une dose sûre de Faboideae erythrina
Calculateur gratuit de posologie — doses adultes et enfants selon le poids.
Erythrina variegata contains curare-like alkaloids, including erysotrine and erythraline, which act as muscle relaxants through neuromuscular blockade. This mechanism is similar to how curare affects muscle function, helping to reduce muscle spasms and associated joint discomfort. The bark also contains flavonoids and tannins with anti-inflammatory properties that may contribute to its traditional use for joint pain. Evidence level: C (preliminary studies and traditional use). The muscle-relaxant effects explain both its therapeutic benefits and potential side effects like muscle weakness at higher doses.
Does Erythrina variegata interact with any medications?
Erythrina variegata may interact with medications affecting the nervous system or muscle function. Due to its curare-like alkaloids, it could enhance the effects of prescription muscle relaxants, anesthetics, and sedatives. The herb may also interact with medications for neuromuscular conditions such as myasthenia gravis. Additionally, the sedative properties could amplify the effects of central nervous system depressants, including benzodiazepines and opioids. Evidence level: C. Patients taking prescription medications should consult a healthcare provider before using Erythrina variegata, especially those on muscle relaxants or neurological medications.
What is the recommended dosage for Erythrina variegata bark?
The traditional Ayurvedic dosage for Erythrina variegata bark is 5-10 grams prepared as a decoction, taken twice daily. This preparation involves boiling the dried bark in water to extract the active compounds. The bark is the primary medicinal part used, and dosages above this range may cause muscle weakness and excessive sedation due to the curare-like alkaloids present. Evidence level: C (traditional use). Dosage should be individualized based on the condition being treated, and treatment should be supervised by a qualified practitioner familiar with this herb.
Is Erythrina variegata safe during pregnancy and breastfeeding?
Erythrina variegata is considered unsafe during pregnancy and should be strictly avoided. The herb contains curare-like alkaloids that can cause muscle relaxation and weakness, which may pose risks to fetal development and normal uterine function. There is insufficient safety data for use during breastfeeding, so it should also be avoided while nursing. Evidence level: C. Women who are pregnant, planning to become pregnant, or breastfeeding should not use Erythrina variegata in any form. Alternative herbs with established safety profiles during pregnancy should be considered instead.
What are the side effects of Erythrina variegata?
The primary side effects of Erythrina variegata are muscle weakness and sedation, particularly when taken in excessive doses. These effects are directly related to the curare-like alkaloids present in the plant, which act on neuromuscular function. Other potential adverse effects include drowsiness and coordination problems. People with neuromuscular conditions such as myasthenia gravis should avoid this herb entirely, as it may worsen muscle weakness. Evidence level: C. Side effects are generally dose-dependent, so staying within recommended dosages of 5-10g twice daily helps minimize risks.
What is Erythrina variegata used for in traditional medicine?
Erythrina variegata has been used in Ayurveda and Southeast Asian folk medicine for centuries. Primary traditional applications include treating joint pain, skin diseases, fever, and various infections. The bark is the most commonly used part, prepared as decoctions for internal use or topical applications for skin conditions. In some traditions, it has been employed as a muscle relaxant for musculoskeletal conditions. The herb's antimicrobial properties have also made it useful for wound healing and skin infections. Evidence level: C. While these uses are well-documented in traditional medicine, more clinical research is needed to validate efficacy.
Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Erythrina variegata is a thorny deciduous tree containing alkaloids, flavonoids, and triterpenoids with demonstrated anti-inflammatory, analgesic, and neuroprotective activities [PMID:39803188, PMID:22228954].
Contexte
Erythrina variegata L. (also known as Erythrina indica or Tiger's Claw) is a thorny deciduous tree of the Fabaceae family distributed in tropical and subtropical regions worldwide, including India, China, Eastern Africa, and Northern Australia [PMID:31600560, PMID:21281246, PMID:22228954].
Usages traditionnels
Traditionally used as a nervine sedative, anxiolytic, and anti-convulsant [PMID:31600560, PMID:22228954]. Other traditional applications include use as a collyrium for opthalmia, antiasthmatic, antiepileptic, antiseptic, astringent, and for the treatment of diabetes mellitus [PMID:22228954, PMID:21281246]. In Thai traditional medicine, it is used in the Mahanintangthong (antipyretic) and Lomammapruek (analgesic and anti-inflammatory) remedies [PMID:29926696].
Composés actifs
The plant contains a wide range of chemical compounds, including monomeric and dimeric erythrinan alkaloids (e.g., erythrivarines A-Z) [PMID:35292327, PMID:36586624, PMID:30178271], isoflavonoids (e.g., eryvarin A, B, Y, Z) [PMID:10985092, PMID:25924538], flavonoids, triterpenoids, lectins [PMID:39803188, PMID:22228954], and coumarins such as xanthoxyletin [PMID:21875271].
Mécanisme d'action
Anti-inflammatory effects are mediated through the inhibition of prostaglandin production via COX-2 and the inhibition of lipopolysaccharide-induced nitric oxide production [PMID:29926696]. Analgesic activity is associated with interaction with COX-1 and COX-2 enzymes [PMID:25489172]. Anti-depressant activity may involve the regulation of monoamine oxidase activity in the brain [PMID:31600560]. Osteoprotective effects occur through the suppression of bone resorption [PMID:20487580].
Preuves cliniques
Preuve DInflammation/Pain
Ethanolic extract increased pain threshold in dose-dependent manner in animal models (acetic acid-induced writhing, hot plate, and tail immersion tests) [PMID:25489172] and inhibited COX-2 and nitric oxide production in vitro [PMID:29926696].
Preuve DDepression/Anxiety
Bark ethanolic extract showed anti-depressant and anxiolytic effects in mice, increasing open arm entries in elevated plus maze and time in light chambers [PMID:31600560, PMID:32127825].
Preuve DOsteoporosis
Oral administration in ovariectomized rats prevented increase in serum OCN, ALP, and urinary DPD, and improved biomechanical properties of bone [PMID:16920298, PMID:20487580].
Preuve DDiabetes
Methanol extract of leaves significantly reduced fasting blood glucose levels in streptozotocin-induced diabetic rats [PMID:21281246].
Preuve DHearing Loss (Neuroprotection)
Erythrivarine T and erythrivarine N showed potential as protectors of HEI-OC-1 cells against neomycin-induced damage [PMID:35292327, PMID:34546728].
Preuve D
Sécurité et effets indésirables
Certain isolated alkaloids showed no cytotoxicity in cell screening bioassays [PMID:32130690].
Synthèse des preuves
The evidence consists primarily of in vitro studies, computational docking, and animal models (rats/mice). There are no human clinical trials (RCTs) or systematic reviews provided; therefore, the overall strength of evidence is low (Level D).
Sources PubMed
1.PMID: 35292327 (2022) — Dimeric Erythrina alkaloids as well as their key units from Erythrina variegata. · Phytochemistry
2.PMID: 30178271 (2018) — An Update of Erythrinan Alkaloids and Their Pharmacological Activities. · Progress in the chemistry of organic natural products
3.PMID: 8510467 (1993) — Saving the ethnopharmacological heritage of Samoa. · Journal of ethnopharmacology
4.PMID: 36586624 (2023) — Dimeric alkaloids from the barks of Erythrina variegata as well as their occurrence. · Fitoterapia
5.PMID: 39803188 (2025) — The Complete Chloroplast Genome of Erythrina variegata L. (Papilionoideae, Fabaceae). · Ecology and evolution
6.
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
Bark extracts showed inhibitory activity over acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) [PMID:34532215].
Preuve DCancer (In Vitro)
Xanthoxyletin induced S phase arrest and apoptosis in human gastric adenocarcinoma SGC-7901 cells [PMID:21875271]; certain proteinase inhibitors (EBI) showed cytotoxicity in T-ALL cell lines [PMID:9692201].
PMID: 34532215 (2021) — Erythrina variegata L. bark: an untapped bioactive source harbouring therapeutic properties for the treatment of Alzheimer's disease. · In silico pharmacology
7.PMID: 32130690 (2020) — Artificial Erythrina Alkaloids from Three Erythrina Plants, E. variegata, E. crista-galli and E. arborescens. · Natural products and bioprospecting
8.PMID: 25489172 (2014) — Molecular docking and analgesic studies of Erythrina variegata׳s derived phytochemicals with COX enzymes. · Bioinformation
9.PMID: 31600560 (2020) — Anti-depressant activity of Erythrina variegata bark extract and regulation of monoamine oxidase activities in mice. · Journal of ethnopharmacology
10.PMID: 22228954 (2010) — Erythrina variegata Linn: A review on morphology, phytochemistry, and pharmacological aspects. · Pharmacognosy reviews
11.PMID: 25470209 (2014) — Dimeric Erythrina alkaloids from the flower of Erythrina variegata. · Organic letters
12.PMID: 10985092 (2000) — Two new isoflavonoids from Erythrina variegata. · Planta medica
13.PMID: 29926696 (2016) — Anti-inflammatory Activities of Erythrina variegata Bark Ethanolic Extract. · Journal of the Medical Association of Thailand = Chotmaihet thangphaet
14.PMID: 34546728 (2021) — Colored Dimeric Alkaloids from the Barks of Erythrina variegata and Their Neuroprotective Effects. · The Journal of organic chemistry
15.PMID: 32127825 (2019) — Anxiolytic and anti-depressant effects of hydroalcoholic extract from Erythrina variegata and its possible mechanism of action. · African health sciences
16.PMID: 16920298 (2007) — Anti-osteoporotic effect of Erythrina variegata L. in ovariectomized rats. · Journal of ethnopharmacology
17.PMID: 21281246 (2011) — Hypoglycemic activity of Erythrina variegata leaf in streptozotocin-induced diabetic rats. · Pharmaceutical biology
18.PMID: 20487580 (2010) — Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption. · The British journal of nutrition
19.PMID: 27555226 (2016) — Phytochemical Profile of Erythrina variegata by Using High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectroscopy Analyses. · Journal of acupuncture and meridian studies
20.PMID: 21875271 (2011) — Xanthoxyletin, a coumarin induces S phase arrest and apoptosis in human gastric adenocarcinoma SGC-7901 cells. · Asian Pacific journal of cancer prevention : APJCP
21.PMID: 9692201 (1998) — Cytotoxicity induced by Erythrina variegata serine proteinase inhibitors in tumor hematopoietic stem cell lines. · Bioscience, biotechnology, and biochemistry
22.PMID: 1517319 (1992) — Isolation and characterization of isolectins from Erythrina variegata seeds. · Journal of chromatography
23.PMID: 25924538 (2015) — Two new isoflavanones from the roots of Erythrina variegata. · Natural product communications